Aarti Pharmalabs Limited (AARTIPHARM.BO)
INR 642.25
(-1.17%)
INR 642.25
(-1.17%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.16 Billion INR | 12.1% |
| 2022 | 1.93 Billion INR | 250941.22% |
| 2021 | -771.37 Thousand INR | -1578.37% |
| 2020 | -45.96 Thousand INR | 75.39% |
| 2019 | -186.75 Thousand INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 546.22 Million INR | -1.5% |
| 2024 Q1 | 554.53 Million INR | -15.02% |
| 2023 Q3 | 527.6 Million INR | 1.85% |
| 2023 FY | 2.16 Billion INR | 12.1% |
| 2023 Q4 | 652.52 Million INR | 23.68% |
| 2023 Q2 | 518 Million INR | 9.99% |
| 2023 Q1 | 470.93 Million INR | 9.84% |
| 2022 Q3 | 476.9 Million INR | -6.65% |
| 2022 FY | 1.93 Billion INR | 250941.22% |
| 2022 Q2 | 510.9 Million INR | -1.45% |
| 2022 Q1 | 518.4 Million INR | -15.2% |
| 2022 Q4 | 428.76 Million INR | -10.09% |
| 2021 Q2 | -77.97 Thousand INR | 0.0% |
| 2021 Q1 | -77.97 Thousand INR | 0.0% |
| 2021 Q4 | 611.32 Million INR | -0.0% |
| 2021 Q3 | 611.34 Million INR | 784141.88% |
| 2021 FY | -771.37 Thousand INR | -1578.37% |
| 2020 FY | -45.96 Thousand INR | 75.39% |
| 2019 FY | -186.75 Thousand INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 64.778% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 93.164% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 53.938% |
| Granules India Limited | 4.05 Billion INR | 46.485% |
| Indoco Remedies Limited | 984.6 Million INR | -120.294% |
| Achyut Healthcare Limited | 5.73 Million INR | -37740.544% |
| Ajanta Pharma Limited | 8.16 Billion INR | 73.424% |
| Alkem Laboratories Limited | 17.95 Billion INR | 87.922% |
| Alpa Laboratories Limited | 167.76 Million INR | -1192.892% |
| Brooks Laboratories Limited | -195.91 Million INR | 1207.1% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -34.296% |
| Bajaj HealthCare Limited | -837.93 Million INR | 358.854% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -187.462% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 96.105% |
| Eris Lifesciences Limited | 3.91 Billion INR | 44.665% |
| FDC Limited | 3.05 Billion INR | 28.937% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 114.444% |
| Gufic Biosciences Limited | 861.35 Million INR | -151.815% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 48.475% |
| Ipca Laboratories Limited | 5.47 Billion INR | 60.372% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -865.597% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 1199.44% |
| Lasa Supergenerics Limited | -217.3 Million INR | 1098.141% |
| Laurus Labs Limited | 1.6 Billion INR | -35.099% |
| Lupin Limited | 19.14 Billion INR | 88.67% |
| Mankind Pharma Limited | 19.12 Billion INR | 88.661% |
| Medicamen Biotech Limited | 109.31 Million INR | -1884.283% |
| Medico Remedies Limited | 82.9 Million INR | -2516.145% |
| Megasoft Limited | -127.46 Million INR | 1801.646% |
| NATCO Pharma Limited | 13.88 Billion INR | 84.376% |
| Piramal Pharma Limited | 178.2 Million INR | -1117.183% |
| RPG Life Sciences Limited | 876.6 Million INR | -147.436% |
| Sigachi Industries Limited | 571.8 Million INR | -279.331% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 97.735% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 27.767% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -756.839% |
| Unichem Laboratories Limited | -704.74 Million INR | 407.775% |
| Wanbury Limited | 559.56 Million INR | -287.627% |
| Windlas Biotech Limited | 581.87 Million INR | -272.767% |
| ZIM Laboratories Limited | 172.46 Million INR | -1157.665% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 94.38% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 156.016% |
| Divi's Laboratories Limited | 16 Billion INR | 86.444% |
| Hester Biosciences Limited | 188.89 Million INR | -1048.298% |
| Procter & Gamble Health Limited | 2 Billion INR | -7.922% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -382.298% |
| Bal Pharma Limited | 73.92 Million INR | -2834.201% |
| Strides Pharma Science Limited | -706.14 Million INR | 407.166% |
| Venus Remedies Limited | 284.9 Million INR | -661.305% |
| Nectar Lifesciences Limited | 49.95 Million INR | -4242.382% |
| Shilpa Medicare Limited | 318.74 Million INR | -580.494% |
| Aarti Drugs Limited | 1.71 Billion INR | -26.534% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -61.349% |
| Suven Life Sciences Limited | -1.05 Billion INR | 306.423% |
| Ind-Swift Limited | 142.31 Million INR | -1424.119% |
| Valiant Laboratories Limited | 3.19 Million INR | -67766.708% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 60.751% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 138.228% |
| Themis Medicare Limited | 435.23 Million INR | -398.353% |
| Hikal Limited | 696.02 Million INR | -211.632% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 86.905% |
| Sequent Scientific Limited | -358.69 Million INR | 704.706% |
| Novartis India Limited | 851.9 Million INR | -154.61% |
| Wockhardt Limited | -4.63 Billion INR | 146.847% |
| Jubilant Pharmova Limited | 771 Million INR | -181.326% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -30484.038% |
| Neuland Laboratories Limited | 3 Billion INR | 27.718% |
| Morepen Laboratories Limited | 961.59 Million INR | -125.564% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -1385.488% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 2490.974% |